Nanjing Superyears Gene Technology Co.
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $8.2M
Investors
- 3
About Nanjing Superyears Gene Technology Co.
, Ltd. operates as a biotechnology company that focuses on life science instruments R&D and manufacturing. It has passed ISO9001 and ISO13485 quality management system certification. In December 2019, the company was recognized as a high-tech enterprise. In 2020, it developed a real-time fluorescence quantitative PCR instrument. The company engages in the research and development of life science instruments. Its products include the Classic series genetic analyzer, Honor series forensic genetic analyzer, real-time fluorescence PCR instrument, gradient PCR instrument and nucleic acid extractor.
Who invested in Nanjing Superyears Gene Technology Co.
3 investors across 1 round
See all investors in Nanjing Superyears Gene Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 24, 2023
Amount
$8.2M
Investors
Questions about Nanjing Superyears Gene Technology Co.
Who invested in Nanjing Superyears Gene Technology Co.?
Nanjing Superyears Gene Technology Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nanjing Superyears Gene Technology Co. raised?
Nanjing Superyears Gene Technology Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nanjing Superyears Gene Technology Co. last raise money?
Nanjing Superyears Gene Technology Co.'s most recent round on record is a Series A, in Sep 2023.
What does Nanjing Superyears Gene Technology Co. do?
Nanjing Superyears Gene Technology Co. is a medical devices & equipment company.
Where is Nanjing Superyears Gene Technology Co. headquartered?
Nanjing Superyears Gene Technology Co. is headquartered in Nanjing, China.
Which VCs invest in companies like Nanjing Superyears Gene Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Nanjing Superyears Gene Technology Co.'s stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Nanjing Superyears Gene Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.